THUMPD3-AS1通过miR-320d/ARF1轴抑制卵巢癌细胞亡
Qingling Mu1, Xin Wang1, Kui Huang2
1Department of Gynecology and Obstetrics, Qingdao Municipal Hospital, Qingdao, Shandong, China.
概括
THUMPD3-AS1通过海绵化miR-320d促进卵巢癌,导致ARF1增加和亡减少. 针对这种长非编码RNA (lncRNA) 途径为卵巢癌提供了潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 卵巢癌是一种流行的妇科恶性瘤,预后不佳.
- 像THUMPD3-AS1这样的长非编码RNA (lncRNAs) 被认为是各种癌症中的癌基因.
- 在卵巢癌中观察到miR-320d和ARF1的失调,但THUMPD3-AS1的作用尚不清楚.
研究的目的:
- 为了阐明THUMPD3-AS1在卵巢癌中的作用.
- 研究涉及miR-320d和ARF1.1的潜在分子机制.
- 评估THUMPD3-AS1作为卵巢癌的潜在治疗标.
主要方法:
- 在体外实验中使用人类卵巢上皮和癌症细胞系.
- 检测细胞活力 (CCK-8),细胞亡 (流细胞计,TUNEL) 和蛋白质/mRNA水平 (西部斑,RT-qPCR).
- 双化酶试验验证THUMPD3-AS1,miR-320d和ARF1.1之间的准关系.
主要成果:
- 在卵巢癌细胞中,THUMPD3-AS1和ARF1的表达高,而miR-320d的表达低.
- THUMPD3-AS1 knockdown 抑制了细胞活力和诱导了细胞亡.
- THUMPD3-AS1作为一个miR-320d海绵,调节ARF1并抑制细胞亡.
结论:
- THUMPD3-AS1通过调节miR-320d/ARF1轴来促进卵巢癌的进展.
- THUMPD3-AS1/miR-320d/ARF1通路是卵巢癌治疗的潜在治疗标.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K


